Cancer testing

A Pilot Study to evaluate a smart-phone based cervical imaging device in Cervical Cancer Screening Program - A Indian Study

Status

Recruiting

Phases

Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2017/08/009335

Enrollment

600

Registered

2017-08-10

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Cervical Screening

Interventions

Intervention1: NIL: NIL Control Intervention1: NIL: NIL

Eligibility

Inclusion criteria

Inclusion criteria: Subject is able to read, understand and sign the informed consent form

Exclusion criteria

Exclusion criteria: Subjects with documented dementia or any other mental disorders, which would render them unable to cooperate with the study requirements Not willing to sign Informed Consent Form

Design outcomes

Primary

Measure	Time frame
Increase of negative predictive value (NPV) of the primary screening test to reduce unnecessary referrals to colposcopy and increase of positive predictive value (PPV) in the primary screening test around staging of pre-cancer and cancer, to ensure that women who are at risk for cervical cancer are caught in time for treatmentTimepoint: day 1	—

Secondary

Measure	Time frame
NilTimepoint: Nil	—

Countries

India

Contacts

Public ContactDr Mallika Samuel

mallikamsamuel@gmail.com

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026